The Unknown Limits of Synthetic Biology
By Helia Ighani,
Council on Foreign Relations
| 02. 13. 2015
Untitled Document
Since 2001, major metropolitan cities have increasingly conducted gas and chemical attack simulations in subway systems. Police departments carry out these exercises with odorless, colorless, and non-toxic gases to determine how to evacuate passengers in the event of an actual biological or chemical attack, and identify safeguards that could be implemented to prevent potentially catastrophic consequences.
Demands for these simulations are based on real ambitions by terrorist groups to acquire biological and chemical weapons. Most recently, a laptop belonging to a member of ISIS (the Islamic State of Iraq and Syria) was found to contain instructions in Arabic on how to develop biological weapons and weaponize the bubonic plague from infected animals. The nineteen-page document suggested using “small grenades with the virus and throw them in closed areas like metros, soccer stadiums, or entertainment centers.” While these terrorist groups may not yet be capable of carrying out such sophisticated attacks, these types of weapons are definitely on their radar. Al-Qaeda has also attempted to develop chemical weapons, even before the 9/11 attacks, and the United States has regularly...
Related Articles
By Emma Cieslik, Ms. Magazine | 11.20.2025
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Adam Feuerstein, Stat | 11.20.2025
The Food and Drug Administration was more than likely correct to reject Biohaven Pharmaceuticals’ treatment for spinocerebellar ataxia, a rare and debilitating neurodegenerative disease. At the very least, the decision announced Tuesday night was not a surprise to anyone paying attention. Approval...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...